Cargando…
2022 FDA TIDES (Peptides and Oligonucleotides) Harvest
A total of 37 new drug entities were approved in 2022; although that year registered the lowest number of drug approvals since 2016, the TIDES class consolidated its presence with a total of five authorizations (four peptides and one oligonucleotide). Interestingly, 23 out of 37 drugs were first-in-...
Autores principales: | Al Musaimi, Othman, Al Shaer, Danah, Albericio, Fernando, de la Torre, Beatriz G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056021/ https://www.ncbi.nlm.nih.gov/pubmed/36986436 http://dx.doi.org/10.3390/ph16030336 |
Ejemplares similares
-
2019 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Shaer, Danah, et al.
Publicado: (2020) -
2020 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2021) -
2021 FDA TIDES (Peptides and Oligonucleotides) Harvest
por: Al Shaer, Danah, et al.
Publicado: (2022) -
2018 FDA Tides Harvest
por: Al Shaer, Danah, et al.
Publicado: (2019) -
2017 FDA Peptide Harvest
por: Al Musaimi, Othman, et al.
Publicado: (2018)